Infinion Biopharma files draft papers with Sebi to mop-up funds through IPO

Infinion Biopharma has filed preliminary papers with capital markets regulator Sebi to raise funds through an initial share sale. The initial public offering (IPO) comprises the sale of 45 lakh equity shares of Infinion Biopharma, draft red herring prospectus (DRHP) filed with Sebi showed.

The company may consider a pre-IPO placement of up to 7 lakh equity shares. Proceeds from the IPO will be used towards investment in Mobius Biomedical Inc, acquisition of licenses for product development of skin care and women's health products and working capital requirements.

At 29, August sees highest IPO filings in 17 years